A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
Clinical trial NCT07112833 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07112833
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-10
- Primary completion
- 2025-08-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.